{"entity":{"type":"insider","cik":"0001292404","url":"/insider/0001292404","json_url":"/insider/0001292404.json","name":"Beck John W","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":26,"n_filings":14,"first":"2006-11-13","last":"2012-06-12","span_basis":"filed_date"},"name_variants":[{"name":"Beck John W","source":"filing","n_filings":14,"first_seen":"2006-11-13","last_seen":"2012-06-12"}],"transactions":[{"id":2707563,"accession":"0001209191-12-033545","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-12-033545","line_url":"/filing/0001209191-12-033545#line-2","is_derivative":false,"issuer_cik":"0001103390","issuer_name":"Ardea Biosciences, Inc./DE","issuer_ticker":"RDEA","issuer_name_source":null,"issuer_url":"/issuer/0001103390","owner_cik":"0001292404","owner_name":"Beck John W","owner_display_name":"Beck John W","owner_url":"/insider/0001292404","role":"Officer (SVP, Finance & Operations, CFO)","role_mark":"O","role_mark_label":"Officer (SVP, Finance & Operations, CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Finance & Operations, CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28048.0,"shares_display":"28,048","price_per_share":31.97,"price_display":"31.97","price_state":"stated","total_value":896694.56,"total_display":"896,694.56","total_whole":"896,695","shares_owned_after":4409.0,"shares_owned_after_display":"4,409","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-06-11","filed_date":"2012-06-12","scope":"insider"},{"id":8978476,"accession":"0001209191-11-041036","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-11-041036","line_url":"/filing/0001209191-11-041036#line-2","is_derivative":false,"issuer_cik":"0001103390","issuer_name":"Ardea Biosciences, Inc./DE","issuer_ticker":"RDEA","issuer_name_source":null,"issuer_url":"/issuer/0001103390","owner_cik":"0001292404","owner_name":"Beck John W","owner_display_name":"Beck John W","owner_url":"/insider/0001292404","role":"Officer (SVP, Finance & Operations, CFO)","role_mark":"O","role_mark_label":"Officer (SVP, Finance & Operations, CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Finance & Operations, CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16000.0,"shares_display":"16,000","price_per_share":24.4632,"price_display":"24.46","price_state":"stated","total_value":391411.2,"total_display":"391,411.20","total_whole":"391,411","shares_owned_after":4409.0,"shares_owned_after_display":"4,409","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-07-25","filed_date":"2011-07-26","scope":"insider"},{"id":5929337,"accession":"0001209191-09-040971","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-09-040971","line_url":"/filing/0001209191-09-040971#line-3","is_derivative":false,"issuer_cik":"0001103390","issuer_name":"Ardea Biosciences, Inc./DE","issuer_ticker":"RDEA","issuer_name_source":null,"issuer_url":"/issuer/0001103390","owner_cik":"0001292404","owner_name":"Beck John W","owner_display_name":"Beck John W","owner_url":"/insider/0001292404","role":"Officer (SVP, Finance & Operations, CFO)","role_mark":"O","role_mark_label":"Officer (SVP, Finance & Operations, CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Finance & Operations, CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":20.1539,"price_display":"20.15","price_state":"stated","total_value":50384.75,"total_display":"50,384.75","total_whole":"50,385","shares_owned_after":885.0,"shares_owned_after_display":"885","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-08-14","filed_date":"2009-08-17","scope":"insider"},{"id":5665100,"accession":"0001209191-09-028205","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-09-028205","line_url":"/filing/0001209191-09-028205#line-2","is_derivative":false,"issuer_cik":"0001103390","issuer_name":"Ardea Biosciences, Inc./DE","issuer_ticker":"RDEA","issuer_name_source":null,"issuer_url":"/issuer/0001103390","owner_cik":"0001292404","owner_name":"Beck John W","owner_display_name":"Beck John W","owner_url":"/insider/0001292404","role":"Officer (SVP, Finance & Operations, CFO)","role_mark":"O","role_mark_label":"Officer (SVP, Finance & Operations, CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Finance & Operations, CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":14.9734,"price_display":"14.97","price_state":"stated","total_value":74867.0,"total_display":"74,867.00","total_whole":"74,867","shares_owned_after":885.0,"shares_owned_after_display":"885","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-05-20","filed_date":"2009-05-21","scope":"insider"},{"id":7775454,"accession":"0001179110-07-013622","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001179110-07-013622","line_url":"/filing/0001179110-07-013622","is_derivative":false,"issuer_cik":"0001053221","issuer_name":"METABASIS THERAPEUTICS INC","issuer_ticker":"MBRX","issuer_name_source":null,"issuer_url":"/issuer/0001053221","owner_cik":"0001292404","owner_name":"Beck John W","owner_display_name":"Beck John W","owner_url":"/insider/0001292404","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3400.0,"shares_display":"3,400","price_per_share":8.07245,"price_display":"8.07","price_state":"stated","total_value":27446.33,"total_display":"27,446.33","total_whole":"27,446","shares_owned_after":236234.0,"shares_owned_after_display":"236,234","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-06-19","filed_date":"2007-06-21","scope":"insider","n_lines":5},{"id":7376356,"accession":"0001179110-07-012204","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-07-012204","line_url":"/filing/0001179110-07-012204","is_derivative":false,"issuer_cik":"0001053221","issuer_name":"METABASIS THERAPEUTICS INC","issuer_ticker":"MBRX","issuer_name_source":null,"issuer_url":"/issuer/0001053221","owner_cik":"0001292404","owner_name":"Beck John W","owner_display_name":"Beck John W","owner_url":"/insider/0001292404","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10035.0,"shares_display":"10,035","price_per_share":8.00039860488291,"price_display":"8.00","price_state":"stated","total_value":80284.0,"total_display":"80,284.00","total_whole":"80,284","shares_owned_after":400.0,"shares_owned_after_display":"400","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-06-01","filed_date":"2007-06-05","scope":"insider","n_lines":2},{"id":7875022,"accession":"0001179110-07-011257","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-07-011257","line_url":"/filing/0001179110-07-011257#line-1","is_derivative":false,"issuer_cik":"0001053221","issuer_name":"METABASIS THERAPEUTICS INC","issuer_ticker":"MBRX","issuer_name_source":null,"issuer_url":"/issuer/0001053221","owner_cik":"0001292404","owner_name":"Beck John W","owner_display_name":"Beck John W","owner_url":"/insider/0001292404","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":2400.0,"total_display":"2,400.00","total_whole":"2,400","shares_owned_after":239634.0,"shares_owned_after_display":"239,634","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-05-22","filed_date":"2007-05-24","scope":"insider"},{"id":7164625,"accession":"0001179110-07-008399","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-07-008399","line_url":"/filing/0001179110-07-008399#line-1","is_derivative":false,"issuer_cik":"0001053221","issuer_name":"METABASIS THERAPEUTICS INC","issuer_ticker":"MBRX","issuer_name_source":null,"issuer_url":"/issuer/0001053221","owner_cik":"0001292404","owner_name":"Beck John W","owner_display_name":"Beck John W","owner_url":"/insider/0001292404","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3300.0,"shares_display":"3,300","price_per_share":8.13,"price_display":"8.13","price_state":"stated","total_value":26829.0,"total_display":"26,829.00","total_whole":"26,829","shares_owned_after":239934.0,"shares_owned_after_display":"239,934","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-04-25","filed_date":"2007-04-25","scope":"insider"},{"id":7249110,"accession":"0001179110-07-007678","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-07-007678","line_url":"/filing/0001179110-07-007678#line-2","is_derivative":false,"issuer_cik":"0001053221","issuer_name":"METABASIS THERAPEUTICS INC","issuer_ticker":"MBRX","issuer_name_source":null,"issuer_url":"/issuer/0001053221","owner_cik":"0001292404","owner_name":"Beck John W","owner_display_name":"Beck John W","owner_url":"/insider/0001292404","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6172.0,"shares_display":"6,172","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":49376.0,"total_display":"49,376.00","total_whole":"49,376","shares_owned_after":10035.0,"shares_owned_after_display":"10,035","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-04-10","filed_date":"2007-04-10","scope":"insider"},{"id":7249108,"accession":"0001179110-07-007678","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-07-007678","line_url":"/filing/0001179110-07-007678#line-1","is_derivative":false,"issuer_cik":"0001053221","issuer_name":"METABASIS THERAPEUTICS INC","issuer_ticker":"MBRX","issuer_name_source":null,"issuer_url":"/issuer/0001053221","owner_cik":"0001292404","owner_name":"Beck John W","owner_display_name":"Beck John W","owner_url":"/insider/0001292404","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1828.0,"shares_display":"1,828","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":14624.0,"total_display":"14,624.00","total_whole":"14,624","shares_owned_after":16207.0,"shares_owned_after_display":"16,207","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-04-09","filed_date":"2007-04-10","scope":"insider"},{"id":7873891,"accession":"0001179110-07-004793","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-07-004793","line_url":"/filing/0001179110-07-004793#line-1","is_derivative":false,"issuer_cik":"0001053221","issuer_name":"METABASIS THERAPEUTICS INC","issuer_ticker":"MBRX","issuer_name_source":null,"issuer_url":"/issuer/0001053221","owner_cik":"0001292404","owner_name":"Beck John W","owner_display_name":"Beck John W","owner_url":"/insider/0001292404","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3300.0,"shares_display":"3,300","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":26400.0,"total_display":"26,400.00","total_whole":"26,400","shares_owned_after":243234.0,"shares_owned_after_display":"243,234","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-02-26","filed_date":"2007-02-27","scope":"insider"},{"id":3881097,"accession":"0001179110-06-022799","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-06-022799","line_url":"/filing/0001179110-06-022799","is_derivative":false,"issuer_cik":"0001053221","issuer_name":"METABASIS THERAPEUTICS INC","issuer_ticker":"MBRX","issuer_name_source":null,"issuer_url":"/issuer/0001053221","owner_cik":"0001292404","owner_name":"Beck John W","owner_display_name":"Beck John W","owner_url":"/insider/0001292404","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":72000.0,"total_display":"72,000.00","total_whole":"72,000","shares_owned_after":6345.0,"shares_owned_after_display":"6,345","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-12-05","filed_date":"2006-12-05","scope":"insider","n_lines":3},{"id":5248257,"accession":"0001179110-06-022483","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-06-022483","line_url":"/filing/0001179110-06-022483","is_derivative":false,"issuer_cik":"0001053221","issuer_name":"METABASIS THERAPEUTICS INC","issuer_ticker":"MBRX","issuer_name_source":null,"issuer_url":"/issuer/0001053221","owner_cik":"0001292404","owner_name":"Beck John W","owner_display_name":"Beck John W","owner_url":"/insider/0001292404","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":8.012,"price_display":"8.01","price_state":"stated","total_value":4006.0,"total_display":"4,006.00","total_whole":"4,006","shares_owned_after":244392.0,"shares_owned_after_display":"244,392","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-11-27","filed_date":"2006-11-29","scope":"insider","n_lines":3},{"id":5302140,"accession":"0001104659-06-074353","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-06-074353","line_url":"/filing/0001104659-06-074353","is_derivative":false,"issuer_cik":"0001053221","issuer_name":"METABASIS THERAPEUTICS INC","issuer_ticker":"MBRX","issuer_name_source":null,"issuer_url":"/issuer/0001053221","owner_cik":"0001292404","owner_name":"Beck John W","owner_display_name":"Beck John W","owner_url":"/insider/0001292404","role":"Officer (Sr. VP, Finance & CFO)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Finance & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Finance & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":72000.0,"total_display":"72,000.00","total_whole":"72,000","shares_owned_after":9345.0,"shares_owned_after_display":"9,345","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-11-08","filed_date":"2006-11-13","scope":"insider","n_lines":3},{"id":7723843,"accession":"0001179110-07-005767","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-07-005767","line_url":"/filing/0001179110-07-005767#line-1","is_derivative":false,"issuer_cik":"0001053221","issuer_name":"METABASIS THERAPEUTICS INC","issuer_ticker":"MBRX","issuer_name_source":null,"issuer_url":"/issuer/0001053221","owner_cik":"0001292404","owner_name":"Beck John W","owner_display_name":"Beck John W","owner_url":"/insider/0001292404","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":8000.0,"total_display":"8,000.00","total_whole":"8,000","shares_owned_after":18035.0,"shares_owned_after_display":"18,035","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-03-01","filed_date":"2007-03-09","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":26,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":26,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":26},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001103390","name":"Ardea Biosciences, Inc./DE","url":"/issuer/0001103390","role":"Officer (SVP, Finance & Operations, CFO)","n_filings":4,"first_seen":"2009-05-21","last_seen":"2012-06-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001053221","name":"METABASIS THERAPEUTICS INC","url":"/issuer/0001053221","role":"Officer (Chief Financial Officer)","n_filings":10,"first_seen":"2006-11-13","last_seen":"2007-06-21"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001292404","retrieved_at":"2026-08-25T00:19:27+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}